These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. In vitro short-term effects of SMS 201-995, bromocriptine and TRH on growth hormone cell morphology from human pituitary adenomas. García García J, Jiménez Reina L, García Luna PP, Leal Cerro A, Astorga Jiménez R, García García-Revillo J, Bernal Valls G. Histol Histopathol; 1989 Apr; 4(2):223-33. PubMed ID: 2520459 [Abstract] [Full Text] [Related]
11. Induction of apoptosis in cells of GH3 line by bromocryptine. Waśko R, Wołuń M, Warchoł JB. Folia Histochem Cytobiol; 1999 Nov 15; 37(2):123-4. PubMed ID: 10352989 [No Abstract] [Full Text] [Related]
13. Bromocriptine-induced changes in hormone secretion and cell morphology in growth hormone and prolactin producing pituitary adenomas. Anniko M, Werner S, Wersäll J. Acta Otolaryngol; 1981 Nov 15; 92(3-4):343-55. PubMed ID: 7324902 [No Abstract] [Full Text] [Related]
19. [Size reduction of a nonfunctioning pituitary adenoma after bromocriptine therapy: case report]. Takahashi T, Kuwayama A, Katoh T, Ichihara K, Kageyama N, Sasaki F. No Shinkei Geka; 1984 Jan 15; 12(1):71-80. PubMed ID: 6717737 [Abstract] [Full Text] [Related]
20. Different responses of growth hormone secretion to guanfacine, bromocriptine, and thyrotropin-releasing hormone in acromegalic patients with pure growth hormone (GH)-containing and mixed GH/prolactin-containing pituitary adenomas. Lamberts SW, Klijn JG, van Vroonhoven CC, Stefanko SZ. J Clin Endocrinol Metab; 1985 Jun 15; 60(6):1148-53. PubMed ID: 3923021 [Abstract] [Full Text] [Related] Page: [Next] [New Search]